Drug price hikes can hurt company reputations: White House

ReutersNewsPublished: August 24, 20165 views
Published: August 24, 2016

White House spokesman Josh Earnest says pharmaceutical firms risk damaging their reputations "by being greedy and jacking up prices" amid criticism over Mylan NV's sharp cost hike of its allergy drug EpiPen. Rough Cut (no reporter narration).

Be the first to suggest a tag